Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early intravenous argatroban plus antiplatelet therapy in acute ischemic stroke with severe intracranial arterial stenosis or non-valvular atrial fibrillation
ChiCTR1900022143Phase 4Not yet recruiting
- Sponsor
- Department of Neurology, The Second Affiliated Hospital of Soochow University
- Start
- Apr 2019
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of argatroban, aspirin, clopidogrel and warfarin in ischemic stroke (4 arms), sponsored by Department of Neurology, The Second Affiliated Hospital of Soochow University. Primary endpoints: New ischemic lesion on follow-up MRI and New intracranial hemorrhage on follow-up MRI. Planned start Apr 2019; status: not yet recruiting.
02
Drugs
argatrobanaspirinclopidogrelwarfarin
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on ChiCTR1900022143.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900022143.